ResearcherYanbian UniversityNo recent work listed

Ran Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6161-205X; OpenAlex author ID A5100687195. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. Co-author DOI 10.3724/abbs.2023066 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yang Dawei · 1 shared paper, 2023 · strength 0.19
- Paper NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. DOI 10.3724/abbs.2023066 ↗
Yang Yang · 1 shared paper, 2023 · strength 0.19
- Paper NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. DOI 10.3724/abbs.2023066 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.